Charles Quesenberry to Estrogen Replacement Therapy
This is a "connection" page, showing publications Charles Quesenberry has written about Estrogen Replacement Therapy.
Connection Strength
0.745
-
Hormone replacement therapy and the risk of myocardial infarction in women with coronary risk factors. Epidemiology. 2000 Sep; 11(5):603-6.
Score: 0.176
-
Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women. Ann Intern Med. 1997 Oct 01; 127(7):501-8.
Score: 0.144
-
Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol. 1996 Jan; 87(1):6-12.
Score: 0.128
-
Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol. 2011 Jan; 69(1):163-9.
Score: 0.089
-
Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008 Apr 16; 100(8):597-8; author reply 599.
Score: 0.075
-
Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998. Circulation. 2003 Jan 07; 107(1):43-8.
Score: 0.052
-
Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy. Stroke. 1998 Jan; 29(1):23-8.
Score: 0.037
-
Risk factors for fracture of the shafts of the tibia and fibula in older individuals. Osteoporos Int. 2006 Jan; 17(1):143-9.
Score: 0.016
-
Reducing the risk for distal forearm fracture: preserve bone mass, slow down, and don't fall! Osteoporos Int. 2005 Jun; 16(6):681-90.
Score: 0.015
-
Risk factors for proximal humerus fracture. Am J Epidemiol. 2004 Aug 15; 160(4):360-7.
Score: 0.014